These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26632896)

  • 21. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
    Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
    Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
    Karakaş Y; Laçin Ş; Kurtulan O; Esin E; Sunar V; Sökmensüer C; Kılıçkap S; Yalçin Ş
    Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.
    Yang M; Zeng L; Hou S; Tian B; Jin S; Zhang Y
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
    Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
    Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 27. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors.
    Araujo PB; Cheng S; Mete O; Serra S; Morin E; Asa SL; Ezzat S
    PLoS One; 2013; 8(4):e61538. PubMed ID: 23620762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
    Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
    J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.
    Rindi G; Klersy C; Albarello L; Baudin E; Bianchi A; Buchler MW; Caplin M; Couvelard A; Cros J; de Herder WW; Delle Fave G; Doglioni C; Federspiel B; Fischer L; Fusai G; Gavazzi F; Hansen CP; Inzani F; Jann H; Komminoth P; Knigge UP; Landoni L; La Rosa S; Lawlor RT; Luong TV; Marinoni I; Panzuto F; Pape UF; Partelli S; Perren A; Rinzivillo M; Rubini C; Ruszniewski P; Scarpa A; Schmitt A; Schinzari G; Scoazec JY; Sessa F; Solcia E; Spaggiari P; Toumpanakis C; Vanoli A; Wiedenmann B; Zamboni G; Zandee WT; Zerbi A; Falconi M
    Neuroendocrinology; 2018; 107(4):375-386. PubMed ID: 30300897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
    You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
    Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
    Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
    J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours.
    Ricci C; Casadei R; Taffurelli G; Campana D; Ambrosini V; Pagano N; Santini D; De Giorgio R; Ingaldi C; Tomassetti P; Zani E; Minni F
    Pancreatology; 2016; 16(3):403-10. PubMed ID: 26924664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
    Hijioka S; Yamashige D; Esaki M; Honda G; Higuchi R; Masui T; Shimizu Y; Ohtsuka M; Kumamoto Y; Katanuma A; Gotohda N; Akita H; Unno M; Endo I; Yokoyama Y; Yamada S; Matsumoto I; Ohtsuka T; Hirano S; Yasuda H; Kawai M; Aoki T; Nakamura M; Hashimoto D; Rikiyama T; Horiguchi A; Fujii T; Mizuno S; Hanada K; Tani M; Hatori T; Ito T; Okuno M; Kagawa S; Tajima H; Ishii T; Sugimoto M; Onoe S; Takami H; Takada R; Miura T; Kurita Y; Kamei K; Mataki Y; Okazaki K; Takeyama Y; Yamaue H; Satoi S;
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1416-1426.e5. PubMed ID: 38615727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A single-institution experience with 176 patients.
    Teo R; Goh BKP; Tai DWM; Allen JC; Lim TKH; Hwang JSG; Tan DM; Lee SY; Chan CY; Cheow PC; Chow PKH; Ooi LLPJ; Chung AYF; Ong S
    Surgery; 2017 May; 161(5):1235-1245. PubMed ID: 28111046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.
    Shiba S; Morizane C; Hiraoka N; Sasaki M; Koga F; Sakamoto Y; Kondo S; Ueno H; Ikeda M; Yamada T; Shimada K; Kosuge T; Okusaka T
    Pancreatology; 2016; 16(1):99-105. PubMed ID: 26718527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
    Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
    Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.